107 related articles for article (PubMed ID: 14697281)
41. Impaired high-shear-stress-induced platelet aggregation in patients with chronic renal failure undergoing haemodialysis.
Yoshida E; Fujimura Y; Ikeda Y; Takeda I; Yamamoto Y; Nishikawa K; Miyataka K; Oonuki M; Kawasaki T; Katayama M
Br J Haematol; 1995 Apr; 89(4):861-7. PubMed ID: 7772523
[TBL] [Abstract][Full Text] [Related]
42. Paradoxical Effect of Nonphysiological Shear Stress on Platelets and von Willebrand Factor.
Chen Z; Mondal NK; Ding J; Koenig SC; Slaughter MS; Wu ZJ
Artif Organs; 2016 Jul; 40(7):659-68. PubMed ID: 26582038
[TBL] [Abstract][Full Text] [Related]
43. Platelets treated with ticlopidine are less reactive to unusually large von Willebrand factor multimers than are those treated with aspirin under high shear stress.
Matsumoto M; Kawaguchi S; Ishizashi H; Yagi H; Iida J; Sakaki T; Fujimura Y
Pathophysiol Haemost Thromb; 2005; 34(1):35-40. PubMed ID: 16293984
[TBL] [Abstract][Full Text] [Related]
44. Shear-stress-induced von Willebrand factor binding to platelets causes the activation of tyrosine kinase(s).
Razdan K; Hellums JD; Kroll MH
Biochem J; 1994 Sep; 302 ( Pt 3)(Pt 3):681-6. PubMed ID: 7524475
[TBL] [Abstract][Full Text] [Related]
45. Complete defect in vWF-cleaving protease activity associated with increased shear-induced platelet aggregation in thrombotic microangiopathy.
Ajzenberg N; Denis CV; Veyradier A; Girma JP; Meyer D; Baruch D
Thromb Haemost; 2002 May; 87(5):808-11. PubMed ID: 12038781
[TBL] [Abstract][Full Text] [Related]
46. Increased platelet aggregability in response to shear stress in acute myocardial infarction and its inhibition by combined therapy with aspirin and cilostazol after coronary intervention.
Tanigawa T; Nishikawa M; Kitai T; Ueda Y; Okinaka T; Makino K; Ito M; Isaka N; Ikeda Y; Shiku H; Nakano T
Am J Cardiol; 2000 May; 85(9):1054-9. PubMed ID: 10781751
[TBL] [Abstract][Full Text] [Related]
47. VWF attributes--impact on thrombus formation.
Reininger AJ
Thromb Res; 2008; 122 Suppl 4():S9-13. PubMed ID: 18929523
[TBL] [Abstract][Full Text] [Related]
48. The role of von Willebrand factor in thrombus formation.
Ruggeri ZM
Thromb Res; 2007; 120 Suppl 1(Suppl 1):S5-9. PubMed ID: 17493665
[TBL] [Abstract][Full Text] [Related]
49. Shear stress-induced binding of von Willebrand factor to platelets.
Konstantopoulos K; Chow TW; Turner NA; Hellums JD; Moake JL
Biorheology; 1997; 34(1):57-71. PubMed ID: 9176590
[TBL] [Abstract][Full Text] [Related]
50. Shear-dependent functions of the interaction between soluble von Willebrand factor and platelet glycoprotein Ib in mural thrombus formation on a collagen surface.
Sugimoto M; Tsuji S; Kuwahara M; Matsui H; Miyata S; Fujimura Y; Yoshioka A
Int J Hematol; 1999 Jan; 69(1):48-53. PubMed ID: 10641443
[TBL] [Abstract][Full Text] [Related]
51. Functional characterization of tissue factor in von Willebrand factor-dependent thrombus formation under whole blood flow conditions.
Matsunari Y; Sugimoto M; Doi M; Matsui H; Kawaguchi M
Int J Hematol; 2016 Dec; 104(6):661-668. PubMed ID: 27562418
[TBL] [Abstract][Full Text] [Related]
52. A novel interpretation of the role of von Willebrand factor in thrombotic microangiopathies based on platelet adhesion studies at high shear rate flow.
Galbusera M; Remuzzi A; Benigni A; Rossi C; Remuzzi G
Am J Kidney Dis; 2000 Oct; 36(4):695-702. PubMed ID: 11007670
[TBL] [Abstract][Full Text] [Related]
53. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of Hb Binding to GP1bα Abrogates Hb-Mediated Thrombus Formation on Immobilized VWF and Collagen under Physiological Shear Stress.
Annarapu GK; Singhal R; Peng Y; Guchhait P
PLoS One; 2016; 11(4):e0154276. PubMed ID: 27105433
[TBL] [Abstract][Full Text] [Related]
55. The chimeric monoclonal antibody MHCSZ-123 against human von Willebrand factor A3 domain inhibits high-shear arterial thrombosis in a Rhesus monkey model.
Ji S; Jiang M; Yan B; Shen F; He Y; Wan A; Xia L; Ruan C; Zhao Y
J Hematol Oncol; 2017 May; 10(1):111. PubMed ID: 28526067
[TBL] [Abstract][Full Text] [Related]
56. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
[TBL] [Abstract][Full Text] [Related]
57. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress.
Ikeda Y; Handa M; Kawano K; Kamata T; Murata M; Araki Y; Anbo H; Kawai Y; Watanabe K; Itagaki I
J Clin Invest; 1991 Apr; 87(4):1234-40. PubMed ID: 2010539
[TBL] [Abstract][Full Text] [Related]
58. Anti-human VWF monoclonal antibody SZ-123 prevents arterial thrombus formation by inhibiting VWF-collagen and VWF-platelet interactions in Rhesus monkeys.
Zhao YM; Jiang M; Ji SD; He Y; Shen F; Li XM; Ruan CG
Biochem Pharmacol; 2013 Apr; 85(7):945-53. PubMed ID: 23295157
[TBL] [Abstract][Full Text] [Related]
59. Highly elevated plasma level of von Willebrand factor accelerates the formation of platelet thrombus under high shear stress in plasma with deficient ADAMTS13 activity.
Yagi H; Yamaguchi N; Shida Y; Sugimoto M; Tubaki K; Fujimura Y; Matsumoto M
Thromb Res; 2017 Nov; 159():91-95. PubMed ID: 29040872
[TBL] [Abstract][Full Text] [Related]
60. Total inhibition of high shear stress induced platelet aggregation by homodimeric von Willebrand factor A1-loop fragments.
Miura S; Sakurai Y; Takatsuka H; Yoshioka A; Matsumoto M; Yagi H; Kokubo T; Ikeda Y; Matsui T; Titani K; Fujimura Y
Br J Haematol; 1999 Jun; 105(4):1092-100. PubMed ID: 10554826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
